A study of vitamin D supplementation on clinical outcome of COVID-19 infected patients with pneumonia

Phase 2

Recruiting

• Conditions: ewly diagnosed COVID-19 pneumonia patients admitted to the hospital for treatment; High-dose vitamin D, COVID-19 pneumonia, clinical outcomes

• Registration Number: TCTR20210906005
• Lead Sponsor: Faculty of Medicine Ramathibodi Hospital, Mahidol University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-09-06
• Study Completion: 2022-05-03
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

1. Aged 18 years and over
2. Diagnosed with COVID-19 pneumonia
3. Agrees to participate in the study

Exclusion Criteria

1. Individuals with gastrointestinal disorders that are unable to take oral medications
2. Diagnosed with sarcoidosis within 1 year
3. Diagnosed with parathyroid gland disease within 1 year
4. Diagnosed with tuberculosis within 1 year
5. Diagnosed with kidney calculi within 1 year
6. Concurrent hypercalcemia with plasma calcium level over 10.6 mg/dL
7. Pregnant or breastfeeding individuals
8. Decline to participate in the study
9. Receipt of palliative therapy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
COVID-19 pneumonia 30 days Modified ordinal scale

Secondary Outcome Measures

Name	Time	Method
Hospitalization 30 days Medical record review